PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Phenazone/lidocaine - Otitis Media
PAD Profile : Phenazone/lidocaine - Otitis Media
Keywords :
Ear drops, local anaesthetic, analgesic, antibiotic, AMR, resistance, NG91
Brand Names Include :
Otigo
Traffic Light Status
Status 1 of 1.
Guidelines
No guidelines returned.
Other Drugs
Other Indications
Additional Documents
Type
Document
Review Date
Evidence Review
Committee Recommendations
Date
Committee Name
Narrative
05 April 2023
Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)
The Surrey Heartlands Integrated Care System Area Prescribing Committee have agreed the use of phenazone 40mg/g with lidocaine 10mg/g ear drops as a treatment option for acute otitis media in line NICE NG91 (acute otitis media antimicrobial prescribing), where oral analgesia has been used and has been ineffective.
A GREEN traffic light status has been agreed for this preparation.
Associated BNF Codes
12. Ear, Nose and Oropharynx
12.01.01. Otitis externa